UNIGE document Scientific Article
previous document  unige:90428  next document
add to browser collection
Title

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
Authors
Ciulla, Thomas A
Harris, Alon
McIntyre, Nathaniel
Jonescu-Cuypers, Christian Paul
Published in Expert Opinion on Pharmacotherapy. 2014, vol. 15, no. 7, p. 953-9
Abstract Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).
Keywords Animals — Delayed-Action Preparations/chemistry — Dexamethasone/administration & dosage/therapeutic use — Diabetic Retinopathy/complications/drug therapy — Drug Implants/administration & dosage/therapeutic use — Fluocinolone Acetonide/administration & dosage/therapeutic use — Glucocorticoids/administration & dosage/therapeutic use — Humans — Intravitreal Injections — Macular Edema/complications/drug therapy — Triamcinolone Acetonide/administration & dosage/therapeutic use
Identifiers
PMID: 24661081
Full text
Article (Published version) (410 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques
Research group Ophtalmologie expérimentale (925)
Citation
(ISO format) 		CIULLA, Thomas A et al. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. In: Expert Opinion on Pharmacotherapy, 2014, vol. 15, n° 7, p. 953-9. doi: 10.1517/14656566.2014.896899 https://archive-ouverte.unige.ch/unige:90428

351 hits

0 download

Contact an author

Update request

Update

Deposited on : 2016-12-15

Export document
Format :
Citation style :